ClinConnect ClinConnect Logo
Search / Trial NCT04271761

Evaluation of Carina Microphone Sensitivity and Maximum Stable Gain in Adult Recipients

Launched by COCHLEAR · Feb 13, 2020

Trial Information

Current as of May 25, 2025

Completed

Keywords

Cochlear Implantation

ClinConnect Summary

The totally implanted Carina System is an active middle ear implant where all components are implanted under the skin. Placing a microphone under the skin affects its acoustic sensitivity and vibration sensitivity. Software is now available to enable non-intrusive microphone measurements in existing patients with the Carina device, through a wireless link to the implant. Detailed knowledge of the acoustic sensitivity of the implanted microphone and objectively measured maximum stable gain, and its inter-individual variability, will allow more accurate calculation of overall system performan...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Eighteen years of age or older at the time of enrolment in the study
  • Current recipient of a Cochlear Carina System.
  • Exclusion Criteria:
  • - Unwillingness or inability of the candidate to comply with all investigational requirements as determined by the Investigator.

About Cochlear

Cochlear Limited is a global leader in implantable hearing solutions, dedicated to transforming the lives of individuals with hearing loss through innovative technology and comprehensive clinical research. With a strong commitment to advancing auditory rehabilitation, Cochlear conducts rigorous clinical trials aimed at evaluating the safety and efficacy of its products, including cochlear implants and bone conduction devices. The company collaborates with healthcare professionals and research institutions worldwide to ensure that its solutions meet the highest standards of quality and performance, ultimately enhancing patient outcomes and promoting accessibility to hearing health care.

Locations

Porto, , Portugal

Patients applied

0 patients applied

Trial Officials

Victor Correia da Silva, MD

Principal Investigator

CUF Porto

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials